{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T14:43:08Z","timestamp":1770216188496,"version":"3.49.0"},"reference-count":31,"publisher":"Japanese Circulation Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn Circ J"],"published-print":{"date-parts":[[2001]]},"DOI":"10.1253\/jcj.65.931","type":"journal-article","created":{"date-parts":[[2002,9,9]],"date-time":"2002-09-09T02:11:39Z","timestamp":1031537499000},"page":"931-936","source":"Crossref","is-referenced-by-count":25,"title":["Comparative Left Ventricular Functional and Neurohumoral Effects of Chronic Treatment With Carvedilol Versus Metoprolol in Patients With Dilated Cardiomyopathy"],"prefix":"10.1253","volume":"65","author":[{"given":"Keiji","family":"Hirooka","sequence":"first","affiliation":[{"name":"Cardiovascular Division, Osaka National Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Yasumura","sequence":"additional","affiliation":[{"name":"Cardiology Division of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Ishida","sequence":"additional","affiliation":[{"name":"Department of Radiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihisa","family":"Hanatani","sequence":"additional","affiliation":[{"name":"Cardiology Division of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Nakatani","sequence":"additional","affiliation":[{"name":"Cardiology Division of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Komamura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Dynamics, Research Institute, National Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatsugu","family":"Hori","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Yamagishi","sequence":"additional","affiliation":[{"name":"Cardiology Division of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunio","family":"Miyatake","sequence":"additional","affiliation":[{"name":"Cardiology Division of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. CIBIS-II Investigators and Committees: The cardiac insufficiency bisoprolol study II (CIBIS-II): A randomized trial. Lancet 1999; 353: 9-13","DOI":"10.1016\/S0140-6736(98)11181-9"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. MERIT-HF Study Group: Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999; 353: 2001-2007","DOI":"10.1016\/S0140-6736(99)04440-2"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, et al: The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 1996; 334: 1349-1355","DOI":"10.1056\/NEJM199605233342101"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Azuma A, Matsuo A, Nakamura T, Kawasaki T, Yamamoto K, Hyogo M, et al: Improved survival in idiopathic cardiomyopathy in the 1990s. Jpn Circ J 1999; 63: 333-338","DOI":"10.1253\/jcj.63.333"},{"key":"5","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1161\/01.CIR.90.4.2153","volume":"90","year":"1994","unstructured":"5. Eichhorn EJ, Hjalmarson A: Beta-blocker treatment for chronic heart failure: The Frog Prince. Circulation 1994; 90: 2153-2156","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"6","doi-asserted-by":"crossref","unstructured":"7. Yue TL, Mckenna PJ, Lysko PG, Gu JL, Lysko KA, Ruffolo RR Jr, et al: SB211475, a metabolite of carvedilol, a novel antihypertensive agent, is a potent antioxidant. Eur J Pharmacol 1994; 251: 237-243","DOI":"10.1016\/0014-2999(94)90405-7"},{"key":"7","unstructured":"8. Yue TL, Cheng HY, Lysko PG, McKenna PJ, Feuerstein R, Gu JL, et al: Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger. J Pharmacol Exp Ther 1992; 263: 92-98"},{"key":"8","doi-asserted-by":"crossref","unstructured":"9. Cleland JG, Bristow MR, Erdmann E, Remme WJ, Swedberg K, Waagstein F: Beta-blocking agents in heart failure. Should they be used and how? Eur Heart J 1996; 17: 1629-1639","DOI":"10.1093\/oxfordjournals.eurheartj.a014745"},{"key":"9","doi-asserted-by":"publisher","unstructured":"10. Gilbert EM, Abraham WT, Olsen S, Hattler B, White M, Mealy P, et al: Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol vs. carvedilol in the failing heart. Circulation 1996; 94: 2817-2825","DOI":"10.1161\/01.CIR.94.11.2817"},{"key":"10","doi-asserted-by":"crossref","unstructured":"11. van Campen LC, Visser FC, Visser CA: Ejection fraction improvement by beta-blocker treatment in patients with heart failure: An analysis of studies published in the literature. J Cardiovasc Pharmacol 1998; 32(Suppl 1): S31-S35","DOI":"10.1097\/00005344-199806321-00006"},{"key":"11","doi-asserted-by":"crossref","unstructured":"12. Sanderson JE, Chan SK, Yip G, Yeung LY, Chan KW, Raymond K, et al: Beta-blockade in heart failure: A comparison of carvedilol with metoprolol. J Am Coll Cardiol 1999; 34: 1522-1528","DOI":"10.1016\/S0735-1097(99)00367-8"},{"key":"12","doi-asserted-by":"publisher","unstructured":"13. Kukin ML, Kalman J, Charney RH, Levy DK, Buchholz-Varley C, Ocampo ON, et al: Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure. Circulation 1999; 99: 2645-2651","DOI":"10.1161\/01.CIR.99.20.2645"},{"key":"13","first-page":"I-664","volume":"94(Suppl I)","year":"1996","unstructured":"14. Lowes BD, Abraham WT, Dutcher DL, Roden RL, Crisman TS, Minobe W, et al: Comparative anti-adrenergic effects of carvedilol and metoprolol in a randomized, placebo-controlled trial (abstract). Circulation 1996; 94(Suppl I): I-664","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"14","unstructured":"15. Chidiac P, Hebert TE, Valiquette M, Dennis M, Bouvier M: Inverse agonist activity of beta-adrenergic antagonists. Mol Pharmacol 1994; 45: 490-499"},{"key":"15","doi-asserted-by":"publisher","unstructured":"16. Bond RA, Leff P, Johnson TD, Milano CA, Rockman HA, McMinn TR, et al: Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the beta 2-adrenoceptor. Nature 1995; 374: 272-276","DOI":"10.1038\/374272a0"},{"key":"16","doi-asserted-by":"crossref","unstructured":"17. Imamura Y, Ando H, Ashihara T, Fukuyama T: Myocardial adrenergic nervous activity is intensified in patients with heart failure without left ventricular volume or pressure overload. J Am Coll Cardiol 1996; 28: 371-375","DOI":"10.1016\/0735-1097(96)00165-9"},{"key":"17","unstructured":"18. Dae MW, De Marco T, Botvinick EH, O'Connell JW, Hattner RS, Huberty JP, et al: Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts: Implications for clinical studies. J Nucl Med 1992; 33: 1444-1450"},{"key":"18","doi-asserted-by":"crossref","unstructured":"19. Bristow MR, Roden RL, Lowes BD, Gilbert EM, Eichhorn EJ: The role of third-generation beta-blocking agents in chronic heart failure. Clin Cardiol 1998; 21(12 Suppl 1): I3-I13","DOI":"10.1002\/clc.4960211303"},{"key":"19","unstructured":"20. Eichhorn EJ, Bristow MR: Practical guidelines for initiation of beta-adrenergic blockade in patients with chronic heart failure. Am J Cardiol 1997; 79: 794-798"},{"key":"20","doi-asserted-by":"crossref","unstructured":"21. Bristow MR: Beta-adrenergic receptor blockade in chronic heart failure. Circulation 2000; 101: 558-569","DOI":"10.1161\/01.CIR.101.5.558"},{"key":"21","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1161\/01.CIR.92.11.3206","volume":"92","year":"1995","unstructured":"22. Grassi G, Seravalle G, Cattaneo BM, Lanfranchi A, Giannattasio C, Del Bo A, et al: Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. Circulation 1995; 92: 3206-3211","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1161\/01.CIR.95.1.169","volume":"95","year":"1997","unstructured":"23. Rundquvist B, Elam M, Bergmann-Sverrisdottir Y, Eisenhofer G, Friberg: Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. Circulation 1997; 95: 169-175","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"23","unstructured":"24. Merlet P, Fumey R, N'Guyen C, Rasetti-Escargueil C, Castaigne A, Syrota A: MIBG imaging in heart failure. Heart Failure 1998; 14: 171-184"},{"key":"24","doi-asserted-by":"publisher","unstructured":"25. Henderson EB, Kahn JK, Corbett JR, Jansen DE, Pippin JJ, Kulkarni P, et al: Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation 1988; 78: 1192-1199","DOI":"10.1161\/01.CIR.78.5.1192"},{"key":"25","doi-asserted-by":"crossref","unstructured":"26. Schofer J, Spielmann R, Schucheert A, Weber K, Schluter M: Iodine-123 meta-iodobenzylguanidine scintigraphy: A noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1988; 12: 1252-1258","DOI":"10.1016\/0735-1097(88)92608-3"},{"key":"26","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1161\/01.CIR.89.6.2843","volume":"89","year":"1994","unstructured":"27. Simmons WW, Freeman MR, Grima EA, Hsia TW, Armstrong PW: Abnormalities of cardiac sympathetic function in pacing-induced heart failure as assessed by [<sup>123<\/sup>I] metaiodobenzylguanidine scintigraphy. Circulation 1994; 89: 2843-2851","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"27","doi-asserted-by":"crossref","unstructured":"28. Cohen-Solal, Esanu Y, Logeart D, Pessione F, Dubois C, Dreyfus G, et al: Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: Relationship with peak oxygen uptake and prognosis. J Am Coll Cardiol 1999; 33: 759-766","DOI":"10.1016\/S0735-1097(98)00608-1"},{"key":"28","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/hrt.81.2.148","volume":"81","year":"1999","unstructured":"29. Kakuchi H, Sasaki T, Ishida Y, Komamura K, Miyatake K: Clinical usefulness of <sup>123<\/sup>I meta-iodobenzylguanidine imaging in predicting the effectiveness of beta blockers for patients with idiopathic dilated cardiomyopathy before and soon after treatment. Heart 1999; 81: 148-152","journal-title":"Heart","ISSN":"https:\/\/id.crossref.org\/issn\/1355-6037","issn-type":"print"},{"key":"29","doi-asserted-by":"crossref","unstructured":"30. Suwa M, Otake Y, Moriguchi A, Ito T, Hirota Y, Kawamura K, et al: Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to beta-blocker therapy in patients with dilated cardiomyopathy. Am Heart J 1997; 133: 353-358","DOI":"10.1016\/S0002-8703(97)70232-1"},{"key":"30","doi-asserted-by":"crossref","unstructured":"31. Fujimura M, Yasumura Y, Ishida Y, Nakatani S, Komamura K, Yamagishi M, et al: Improvement in left ventricular function in response to carvedilol is accompanied by attenuation of neurohumoral activation in patients with dilated cardiomyopathy. J Cardiac Failure 2000; 6: 3-10","DOI":"10.1016\/S1071-9164(00)80004-4"},{"key":"31","doi-asserted-by":"crossref","unstructured":"32. Bristow MR: Mechanism of action of beta-blocking agents in heart failure. Am J Cardiol 1997; 80(11A): 26L-40L","DOI":"10.1016\/S0002-9149(97)00846-1"}],"container-title":["Japanese Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcj\/65\/11\/65_11_931\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T17:27:26Z","timestamp":1583515646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcj\/65\/11\/65_11_931\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2001]]}},"URL":"https:\/\/doi.org\/10.1253\/jcj.65.931","relation":{},"ISSN":["0047-1828","1347-4839"],"issn-type":[{"value":"0047-1828","type":"print"},{"value":"1347-4839","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001]]}}}